HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon
L Vergne, S Diagbouga, C Kouanfack… - Antiviral …, 2006 - journals.sagepub.com
We analysed whether mutations associated with resistance to antiretroviral (ARV) drugs
circulate among treatment-naive HIV-1-infected individuals at a period when these drugs …
circulate among treatment-naive HIV-1-infected individuals at a period when these drugs …
HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon.
L Vergne, S Diagbouga, C Kouanfack… - Antiviral …, 2006 - europepmc.org
We analysed whether mutations associated with resistance to antiretroviral (ARV) drugs
circulate among treatment-naive HIV-1-infected individuals at a period when these drugs …
circulate among treatment-naive HIV-1-infected individuals at a period when these drugs …
HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon
L Vergne, S Diagbouga, C Kouanfack… - Antiviral …, 2006 - documentation.ird.fr
The implementation of highly active antiretroviral therapy (HAART) in developed countries
has led to a marked drop in the mortality rate of AIDS patients. Until recently, only few people …
has led to a marked drop in the mortality rate of AIDS patients. Until recently, only few people …
HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon
L Vergne, S Diagbouga, C Kouanfack… - Antiviral …, 2006 - pubmed.ncbi.nlm.nih.gov
We analysed whether mutations associated with resistance to antiretroviral (ARV) drugs
circulate among treatment-naive HIV-1-infected individuals at a period when these drugs …
circulate among treatment-naive HIV-1-infected individuals at a period when these drugs …
[PDF][PDF] HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon
L Vergne, S Diagbouga, C Kouanfack… - Antiviral …, 2006 - researchgate.net
The implementation of highly active antiretroviral therapy (HAART) in developed countries
has led to a marked drop in the mortality rate of AIDS patients. Until recently, only few people …
has led to a marked drop in the mortality rate of AIDS patients. Until recently, only few people …
[引用][C] HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon
L VERGNE, S DIAGBOUGA, H HIEN… - Antiviral therapy …, 2006 - pascal-francis.inist.fr
HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up
programmes in Burkina Faso and Cameroon CNRS Inist Pascal-Francis CNRS Pascal and …
programmes in Burkina Faso and Cameroon CNRS Inist Pascal-Francis CNRS Pascal and …
HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon
L Vergne, S Diagbouga, C Kouanfack, FA Aghokeng… - 2006 - documentation.ird.fr
We analysed whether mutations associated with resistance to antiretroviral (ARV) drugs
circulate among treatment-naive HIV-1-infected individuals at a period when these drugs …
circulate among treatment-naive HIV-1-infected individuals at a period when these drugs …